03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Javlor 50mg : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Pierre Fabre Médicament |
Responsible Party | Pierre Fabre Medicament |
Origin | France |
Manufacturer | Fareva |
Origin | France |
ATC | L01CA05 |
Javlor 50mg :
Javlor 50mg :
Javlor 50mg :
Javlor 50mg :
Javlor 50mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Javlor 50mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Acute respiratory distress syndrome | Uncommon |
Alopecia | Very Common |
Anaemia | Very Common |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Very Common |
Back pain | Common |
Bacterial infection | Common |
Bone pain | Common |
Bronchospasm | Not known |
Chest pain | Common |
Chills | Common |
Constipation | Very Common |
Cough | Common |
Decreased appetite | Very Common |
Dehydration | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Dry skin | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
Dyspepsia | Common |
Dysphagia | Common |
Dyspnoea (dyspnea) | Common |
ECG QT prolonged | Not known |
Erythema | Uncommon |
Extravasation | Uncommon |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Fungal infection | Common |
Gastric disorder | Uncommon |
Gingival disorder | Uncommon |
Headache | Common |
Hyperhidrosis | Common |
Hypersensitivity | Common |
Hypertension | Common |
Hyponatraemia (Hyponatremia) | Very Common |
Hypotension | Common |
Ileus | Common |
Inappropriate antidiuretic hormone secretion (SIADH) | Uncommon |
Injection site reaction | Very Common |
Insomnia | Common |
Jaw pain | Common |
Laryngeal pain | Uncommon |
Leucopenia (Leukopenia) | Very Common |
Muscle weakness | Common |
Musculoskeletal pain | Common |
Myalgia | Very Common |
Myocardial infarction | Uncommon |
Myocardial ischaemia | Uncommon |
Nausea | Very Common |
Neuralgia | Common |
Neuropathy peripheral | Common |
Neutropenia | Very Common |
Neutropenic infection | Common |
Neutropenic sepsis | Uncommon |
Odynophagia | Uncommon |
Oedema | Common |
Oesophagitis | Uncommon |
Oral disorder | Common |
Otalgia (Earache) (Ear pain) | Common |
Pain | Common |
Pain in extremity (Pain in limb) | Common |
Peripheral motor neuropathy | Uncommon |
Peripheral sensory neuropathy | Very Common |
Phlebitis | Common |
Posterior reversible leukoencephalopathy syndrome (PRES) | Rare |
Pruritus | Common |
Pyrexia | Very Common |
Renal failure | Uncommon |
Skin rash | Common |
Stomatitis | Very Common |
Syncope | Common |
Tachycardia | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Tinnitus | Uncommon |
Transaminases increased | Uncommon |
Tumour pain | Uncommon |
Urticaria | Common |
Venous thrombosis | Common |
Vertigo | Uncommon |
Viral infection | Common |
Visual disturbance | Uncommon |
Vomiting | Very Common |
Weight decreased (Weight loss) | Very Common |
Weight increased (weight gain) | Uncommon |
Javlor 50mg :
Different Units By MoH Code
Javlor 50mg MoH 6162 :
Form | Concentrate for solution for infusion |
Packaging | Vial (Type I Glass) |
Package Size | 1x2ml |
Strength | 50mg/2ml |
NSSF | ✘ |
Quarantine | ✔ |
Reg. Number | 167733/10 |
Submission date | 01/01/2010 |
Registration Year | 2011 |
Archived Date | 13/06/2024 |
Price Comparison
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
Note
You have to register to view this info
Drop File